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In response to DNA damage, cells activate a complex, kinase-based signaling network
to arrest the cell cycle and allow time for DNA repair, or, if the extend of damage is
beyond repair capacity, induce apoptosis. This signaling network, which is collectively
referred to as the DNA damage response (DDR), is primarily thought to consist
of two components—a rapid phosphorylation-driven signaling cascade that results in
immediate inhibition of Cdk/cyclin complexes and a delayed transcriptional response that
promotes a prolonged cell cycle arrest through the induction of Cdk inhibitors, such
as p21. In recent years a third layer of complexity has emerged that involves potent
posttranscriptional regulatory mechanisms that control the cellular response to DNA
damage. Although much has been written on the relevance of the DDR in cancer and
on the post-transcriptional role of microRNAs (miRs) in cancer, the post-transcriptional
regulation of the DDR by non-coding RNAs and RNA-binding proteins (RBPs) still remains
elusive in large parts. Here, we review the recent developments in this exciting new area
of research in the cellular response to genotoxic stress. We put specific emphasis on
the role of RBPs and the control of their function through DNA damage-activated protein
kinases.
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CELLS ACTIVATE A COMPLEX SIGNALING NETWORK
IN RESPONSE TO DNA DAMAGE
All life on earth must resist a constant assault on its genomic
integrity by various endogenous and exogenous sources. Stalled
replication forks or incomplete DNA replication during S-phase,
and a plethora of different DNA lesions, such as those ubiqui-
tously induced by UV, ionizing radiation (IR), or reactive oxygen
species, as well as those intentionally provoked by treatment
with chemotherapeutic agents, or radiation therapy used in can-
cer patients, activate a complex, kinase-based signaling network,
which is collectively referred to as the DNA damage response
(DDR). Activation of the DDRnetwork through genotoxic lesions
triggers signal transduction cascades to activate cell cycle check-
points, which prevent further progression through the cell cycle
as long as the lesions persist (Jackson and Bartek, 2009).
The DDR can be subdivided into two major kinase signal-
ing branches: the ATM pathway, acting through the downstream
effector kinase Chk2 and the proximal DDR kinase ATR, act-
ing through Chk1. Some crosstalk exists between the ATM/Chk2
and ATR/Chk1 pathways, particularly when signaling through
one pathway is partially or totally deficient (Kastan and Lim,
2000; Abraham, 2001; Shiloh, 2001, 2003; Bartek and Lukas,
2003). Normally however, the pathways appear to have distinct
functions with only partial functional overlap in response to
particular forms of DNA damage, especially at later stages in
the cell cycle (Jazayeri et al., 2006). Different types of genotoxic
stress are preferentially channeled through one or the other of
these two pathways. The ATM/Chk2 pathway is activated pri-
marily in response to DNA double strand breaks (DSBs), such
as those formed by IR or topoisomerase-2 inhibitors, such as
etoposide or doxorubicin, while the ATR/Chk1 pathway is acti-
vated by bulky DNA lesions induced by UV and in response to
replication fork collapse during S-phase (Zhou and Elledge, 2000;
Abraham, 2001).
A major target of both the ATM/Chk2 and the ATR/Chk1
branch of the DDR are members of the Cdc25 family of dual
specificity phosphatases. Phosphorylation-dependent inhibition
of Cdc25 prevents activation of the Cdk-cyclin complexes that
mediate transition from G1 into S-phase, progression through
S-phase and mitotic entry, thus establishing G1, intra-S-phase,
and G2/M cell cycle checkpoints (Donzelli and Draetta, 2003;
Rudolph, 2007). Cdc25A is required for activation of Cdk2-Cyclin
E and A complexes that govern S-phase entry and progression.
Chk1-mediated phosphorylation of Cdc25A creates a phospho-
degron motif, resulting in SCFβ−TrCP-dependent ubiquitination
and subsequent proteasomal degradation, as the major mecha-
nismof inhibition (Jin et al., 2003). Cdc25B andC are required for
activation of Cdk1-cyclin B complexes mediating mitotic entry.
Upon DNA damage Chk1 and 2 phosphorylate Cdc25B and
C, creating phosphoepitopes that are recognized and bound by
phosphopeptide-binding 14-3-3 proteins (Donzelli and Draetta,
2003; Harper and Elledge, 2007). 14-3-3 serves as a molecular
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chauffeur resulting in cytoplasmic translocation and sequestra-
tion of the complexes, preventing Cdc25B/C from activating
Cdk1-cyclin B complexes.
We and others have recently identified a third cell cycle
checkpoint effector kinase pathway that is governed by p38α/β-
dependent activation of MK2 (Bulavin et al., 2001; Manke et al.,
2005; Raman et al., 2007; Reinhardt et al., 2007, 2010; Reinhardt
and Yaffe, 2009). This pathway is activated in response to UV
and the commonly used chemotherapeutic drugs cisplatin, camp-
tothecin and doxorubicin (Manke et al., 2005; Raman et al.,
2007; Reinhardt et al., 2007). We showed that ATM and ATR are
required to activate the p38/MK2 module after doxorubicin and
cisplatin (Reinhardt et al., 2007). In a series of experiments, we
showed that MK2 functions as a downstream checkpoint effector
kinase that is critical for cellular survival following DNA damage,
specifically in cells and tumors that had lost the prominent tumor
suppressor p53 (Reinhardt et al., 2007, 2009; Reinhardt and Yaffe,
2009). MK2 is required to prevent G1/S, intra-S phase and G2/M
transition after cisplatin and doxorubicin in p53-deficient cells
(Reinhardt et al., 2007). Intriguingly, MK2 appears to operate
in a pathway that is redundant with, but independent of Chk1
(Manke et al., 2005; Reinhardt et al., 2007). Using oriented pep-
tide library screening (OPLS), we determined the amino acid
specificity for MK2 phosphorylation and found that it is identical
to the optimal sequences selected by the checkpoint kinases Chk1
and Chk2 (Manke et al., 2005; Reinhardt et al., 2007). This find-
ing suggested that all three kinases might share a pool of common
substrates. Indeed, we could show that MK2 directly phospho-
rylates Cdc25A and is required for its DNA damage-dependent
degradation, resulting in a G1/S arrest after cisplatin and UV
(Manke et al., 2005; Reinhardt et al., 2007). In response to dox-
orubicin, MK2 phosphorylates Cdc25B and C on known Chk1
sites, generating functional 14-3-3 binding sites and resulting in a
G2/M arrest (Reinhardt et al., 2007). These results suggest that
cells lacking a functional p53 response recruit a general stress
response network—p38/MK2—to arrest the cell cycle after geno-
toxic stress. More importantly, this requirement for the p38/MK2
network in p53-deficient tumors, rationalizes the use of MK2
inhibitors as chemosensitizing agents that are based on the syn-
thetic lethal interaction between the corresponding genes TP53
andMAPKAPK2 (Reinhardt et al., 2009).
In addition to the activation of this canonical DDR kinase
network, which brings about numerous changes in the cellu-
lar signaling circuitry occur as a consequence of posttransla-
tional modifications of proteins functioning within the DDR
network through phosphorylation, ubiquitylation or sumoyla-
tion (Reinhardt and Yaffe, 2009), the pattern of mRNA expression
also undergoes significant changes after DNA damage (Rieger
and Chu, 2004; Reinhardt et al., 2011). For instance, human
lymphoblastoid cells from healthy adults display up- or down-
regulation of thousands of mRNAs following exposure to IR
or ultraviolet light (Rieger and Chu, 2004). Furthermore, tran-
scriptome analysis following MMS or IR treatment showed that
the expression levels of as much as 20% of genes in budding
yeast showed a 2-fold or greater change (Gasch et al., 2001).
These profound transcriptome alterations appear counterintu-
itive at first glance, as de novo transcription of genes shortly after
the infliction of DNA damage might pose a certain threat. The
template DNA strand used for transcription might be damaged,
leading to the transcription of potentially mutated RNA. In addi-
tion, the transcription process is energy-intensive (synthesis of an
RNA molecule with n bases requires at least n NTP molecules)
and relatively time-consuming. Specifically, the temporal compo-
nent imposes a pivotal risk, if the protein product derived from
the transcribed mRNA was rapidly needed for cell cycle arrest,
DNA repair or the induction of apoptosis. Perhaps not surpris-
ingly, DNA damage, such as that induced by UV-C irradiation,
has been shown to trigger a transient repression of transcrip-
tional activity in eukaryotic cells (Vichi et al., 1997; Rockx et al.,
2000). Several molecular mechanisms have been implicated in
mediating this DNA damage-induced global repression of tran-
scriptional activity. RNA Pol II becomes hyperphosphorylated in
response to genotoxic stress and is thus prevented from enter-
ing pre-initiation complexes at promoter sites (Rockx et al.,
2000; Svejstrup, 2002). Furthermore, in vitro evidence suggests
that the TATA-binding protein TBP is sequestered onto damaged
DNA, reducing its availability for transcription (Vichi et al., 1997;
Svejstrup, 2002). The transcriptional repression that is mediated
through these molecular pathways varies depending on the type
and intensity of DNA damage and is reverted upon completion
of DNA repair (Svejstrup, 2002). However, this DNA damage-
induced repression of transcriptional activity immediately poses
the question how cells accomplish the DNA damage-induced
changes in mRNA expression, which have clearly been demon-
strated by numerous groups?
POSTTRANSCRIPTIONAL REGULATION OF THE DNA
DAMAGE RESPONSE
As transcription is globally repressed upon DNA damage, addi-
tional mechanisms that regulate protein biosynthesis from pre-
existing pools of mRNA become critically important to allow
an appropriate cellular DDR. Two posttranscriptional regulatory
mechanisms are at play to control protein expression following
genotoxic stress: (1) selective mRNA stabilization or decay and
(2) regulation of translation. Both of these mechanisms criti-
cally hinge on the function of RNA-binding proteins (RBPs) and
non-coding RNAs, which modulate mRNA stability, transport
and translatability through direct interactions with their client
mRNAs. Thus, in addition to a well-studied plethora of post-
translational modifications, including phosphorylation, ubiquiti-
nation, methylation, acetylation, and others (Harper and Elledge,
2007; Jackson and Bartek, 2009), posttranscriptional control
mechanisms are emerging as a new layer of regulation within the
complex DDR signaling network.
Intriguing in this regard is data that emerged from a
recent phospho-proteomic screen aiming to identify novel ATM/
ATR/DNA-PK substrates. The largest subset of substrates identi-
fied in these experiments were proteins linked to RNA and DNA
metabolism, and specifically proteins involved in posttranscrip-
tionalmRNA regulation (Matsuoka et al., 2007). In addition, gene
products responsible for nucleic acid metabolism, particularly
those involved in mRNA binding and processing, have recently
been identified as the largest subset of “hits” in an RNAi-mediated
loss of function screen to identify modulators of DNA damage
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signaling (Paulsen et al., 2009). Furthermore, data provided by
Gorospe and co-workers re-enforced the role of posttranscrip-
tional regulatory circuits in the control of a large fraction of the
transcriptome in response to genotoxic stress (Fan et al., 2002).
Specifically, cDNA expression arrays were employed to gauge
the relative contribution of transcription and mRNA turnover
to overall changes in gene expression after a variety of cellular
stresses, including UV-C irradiation. In essence, a comparison
of cDNA hybridization patterns of newly transcribed mRNAs
derived from nuclear run-on assays, and steady state mRNA pools
derived from whole cell lysates was performed. These experi-
ments revealed that approximately 50% of the changes in mRNA
steady state levels that were observed after cellular stress, were
attributable to mRNA turnover (stabilization/decay), while the
remaining ∼50% were due to altered transcription. Lastly, apply-
ing a mass spectrometry-based interactome screen, Yaffe and
colleagues identified proteins involved in mRNA splicing and
translation as the largest group of molecules interacting with the
critical DDR protein 14-3-3 (Wilker et al., 2007). These coincid-
ing observations, observed in very different experimental settings,
highlight the potential importance of posttranscriptional regula-
tory mechanisms in the context of DDR signaling, and strongly
argue that the DDRmay extend substantially beyond the classical
ATM/Chk2 and ATR/Chk1 signaling cascades detailed above.
The first links between the kinase-based canonical DDR
and posttranscriptional regulatory mechanisms were established
through the study of p21Cip1/WAF mRNA. p21Cip1/WAF is a canon-
ical p53 target gene and is potently induced in response to
genotoxic stress (el-Deiry et al., 1993). Not only could Wang
et al. show that the RBP HuR (human antigen R or ELAVL1, a
member of the embryonic lethal abnormal vision-like familiy)
formed a ribonucleoprotein (RNP) complex with p21Cip1/WAF
mRNA in RKO colorectal carcinoma cells following UV-C irra-
diation, but also that this complex formation appeared to be
critical for p21Cip1/WAF mRNA stabilization following genotoxic
stress, as HuR depletion impaired p21Cip1/WAF mRNA induc-
tion after UV-C (Wang et al., 2000). Further, the laboratory of
A. Nebreda recently showed that p38MAPK induces p21Cip1/WAF
mRNA stabilization without significantly affecting transcription
of p21Cip1/WAF (Lafarga et al., 2009). p38MAPK-mediated phos-
phorylation of HuR on Thr-118 in response to IR was shown to be
critical for cytoplasmic accumulation of HuR, enhanced binding
to the p21Cip1/WAF mRNA and subsequent p21Cip1/WAF mRNA
and protein accumulation (Lafarga et al., 2009). Further experi-
ments revealed that the shuttling of HuR between the nucleus and
the cytoplasm is tightly regulated by a variety of kinases, includ-
ing Cdk1, Chk2, and MK2 (Tran et al., 2003; Abdelmohsen et al.,
2007; Kim et al., 2008). recently suggested that Chk2, which shares
substrate homology with MK2 (Manke et al., 2005), phosphory-
lates HuR on Ser-88, Ser-100, and Thr-118. This interaction is
likely to occur in the nucleus, since Chk2 and HuR could be co-
immunoprecipitated only from nuclear extracts (Abdelmohsen
et al., 2007). Phosphorylation, particularly on Ser-100 in response
to genotoxic H2O2, decreased the binding affinity of HuR to
its target mRNA SIRT1 (Sirtuin 1), resulting in destabilization
of SIRT1 mRNA, decreased SIRT1 protein levels and increased
sensitivity of WI-38 human diploid fibroblasts to the cytotoxic
effects of H2O2. Mutation of Ser-88 and Thr-118 to Ala reduced
SIRT1 mRNA binding even in the absence of H2O2, suggesting
that phosphorylation on these sites actually promotes HuR RNP
formation. It is, however, also conceivable that these particular
mutations induce conformational changes that preclude effective
RNA binding, since these residues are located within the RNA
recognition motifs (RRMs) of HuR. Interestingly, treatment of
WI-38 cells with H2O2 revealed that binding of wildtype HuR
differed according to the target mRNA: binding of p21Cip1/WAF
mRNA was increased, while decreased on SIRT1 and numerous
cyclin mRNAs. However, mutation of Ser-100 to Ala generally
increased the binding affinity of HuR to all mRNAs tested. These
observations suggest that although Chk2 is clearly activated by
H2O2, this activity does not translate into a uniform decrease
in HuR binding affinity to its target mRNAs. One could spec-
ulate that structural features within the HuR target mRNAs or
the recruitment of other RBPs into the HuR RNPs ultimately
dictate the affinity of HuR to its target mRNAs. It is also possi-
ble that the Chk2 recognition motif in HuR might be masked in
certain RNPs, which could preclude Chk2-mediated phosphory-
lation of Ser-100 in certain RNPs. These questions await further
clarification.
As a member of the ELAV-like family of RBPs, HuR has strong
binding affinity to mRNAs that contain so-called AU-rich ele-
ments (AREs) in their 3′ UTR (Dean et al., 2004). AREs act as
potent mRNA destabilizing elements that target mRNA for rapid
deadenylation (Chen and Shyu, 1994; Xu et al., 1997; Wilson and
Treisman, 1988). AREs can be subdivided into three classes: class
I and II AREs contain copies of an AUUUA pentameric repeat,
called Shaw-Kamen motif (Shaw and Kamen, 1986). Class I AREs
contain 1–3 scattered Shaw-Kamen motifs in the 3′ UTR, class
II AREs contain multiple, partially overlapping AREs in their 3′
UTR, and class III AREs commonly lack the AUUUA pentamer,
but are enriched for U-rich sequence stretches (Dean et al., 2004).
Nagamine and colleagues (Tran et al., 2003) showed that HuR
binds and stabilizes the urokinase plasminogen activator (uPA)
mRNA in an ARE-dependent manner. The authors went on to
show that overexpression of constitutively active MK2 resulted
in stabilization of ARE-containing reporter mRNAs. This effect
correlated with an MK2-dependent cytoplasmic accumulation of
HuR. Furthermore, treatment with H2O2, a known MK2 activat-
ing stimulus, also resulted in cytoplasmic HuR accumulation. The
authors demonstrated that increased binding of HuR to ARE-
containing uPA mRNA and stabilization of an ARE-containing
reporter mRNA in response to H2O2 depended on MK2 acting
downstream of p38MAPK. However, no evidence suggesting that
MK2 directly phosphorylates HuR in this system was presented in
this study.
In contrast to the molecular effect of p38MAPK, Chk2, and
MK2, Cdk1-mediated HuR phosphorylation on Ser-202 was
recently shown to sequester HuR in the nucleus (Kim et al., 2008).
Cdk1 inhibition promoted a cytoplasmic accumulation of HuR,
while a predominately nuclear localization of HuR was observed
under conditions of high Cdk1 activity. Furthermore, a Ser-202 to
Ala mutant form of HuR was located primarily in the cytoplasm,
while phospho-Ser-202 HuR could be detected almost exclusively
in the nucleus. Kim et al. further showed that Cdk1-dependent
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Ser-202 phosphorylation of HuR was essential for 14-3-3θ bind-
ing to HuR. However, it was never formally demonstrated that
the phosphopeptide-binding protein 14-3-3θ directly binds a
phosphoepitope surrounding Ser-202.
Among the known DDR kinases, the p38MAPK/MK2 signal-
ing complex probably has the strongest ties to posttranscriptional
control of gene expression. Anderson and colleagues character-
ized the MK2-mediated regulation of the zinc finger protein
Tristetraprolin (TTP), which had been shown to bind and desta-
bilize ARE-containing mRNAs such as TNFα (Stoecklin et al.,
2004). ARE-containing mRNAs are unstable under normal con-
ditions and are stabilized in response to various cellular stressors,
such as UV, lipopolysaccharides (LPS), or arsenite (Kedersha and
Anderson, 2002). In their experiments, Anderson and colleagues
showed that MK2-mediated phosphorylation of TTP on Ser-52
and Ser-178 in response to arsenite generated a phosphoepi-
tope that was subsequently engaged by 14-3-3 (Stoecklin et al.,
2004). TTP binds to ARE-containing target mRNAs and directs
them to exosome-dependent degradation. TTP:14-3-3 complex
formation resulted in exclusion from stress granules (SGs) and
inhibition of TTP-dependent degradation of ARE-containing
β-globin reporter mRNA. SGs are the morphological correlate of
an abrupt, stress-induced translational arrest resulting in rapid
polyribosome disassembly (Kedersha and Anderson, 2002). These
cytoplasmic granules consist of a number of proteins involved in
RNA metabolism, as well as stalled initiation complexes, which
are bound to numerous mRNAs (Anderson and Kedersha, 2006).
The mRNA molecules from disassembled, stalled polyribosomes
are sorted into SGs where the fate of each individual messen-
ger is determined by RBPs that either promote RNA stabilization
or decay (Kedersha and Anderson, 2002; Kedersha et al., 2005).
SG proteins, such as TIA-1 and HuR, bind to ARE-containing
mRNAs, and control their stability and translation (Anderson and
Kedersha, 2002, 2006; Kedersha and Anderson, 2002; Kedersha
et al., 2005). As an alternative mechanism to TTP:14-3-3 com-
plex formation, it could be shown that phosphorylation of TTP
by MK2 blocks mRNA decay by inhibiting the recruitment of the
CCR4-CAF1 deadenylase complex (Marchese et al., 2010).
Like TTP, BRF1, subunit of the RNA polymerase III, is an
ARE-binding protein that has recently been shown to be a direct
substrate of MK2. Phosphorylation of BRF1 on four distinct
residues (Ser-54, Ser-92, Ser-203, and an unidentified site in
the C-terminus) reduced the ability of BRF1 to promote ARE-
mediated decay. However, the mechanistic details of this effect
remain somewhat unclear (Maitra et al., 2008).
Besides TTP and BRF1, which promote ARE-mediated decay,
MK2 has also been shown to directly phosphorylate hnRNP A0, a
protein that specifically interacts with ARE-containing mRNAs,
exerting a stabilizing effect on its RNA targets. Rousseau et al.
(2002) identified hnRNP A0 (heterogeneous nuclear RNP A0)
as a protein with binding affinity for the AREs in the 3′ UTR
of TNFα in macrophage lysates. They further showed that MK2
phosphorylates hnRNP A0 on Ser-84 following LPS treatment.
Pharmacological inhibition of p38MAPK abrogated hnRNP A0
binding to its MIP-2 (macrophage inflammatory protein 2)
client mRNA and impaired MIP-2 mRNA stability and protein
induction. Together these findings suggest that MK2-dependent
phosphorylation of hnRNPA0 is required for mRNA binding and
stabilization.
A number of other RBPs have been identified as MK2
substrates in vitro, however, the functional relevance of these
phosphorylation events remains elusive and awaits further inves-
tigation. For example, Bollig and colleagues identified PABP1
(Polyadenylate-binding protein 1) as a GM-CSF (Granulocyte
macrophage colony-stimulating factor) ARE-binding protein,
which can be efficiently phosphorylated by MK2 in vivo (Bollig
et al., 2003). Whether this phosphorylation takes place in vivo
and what influence it might have on GM-CSF mRNA stability or
translation remains unclear.
Although, defects in RBPs have been associated with a
large number of diseases, our current knowledge is largely
still restricted to canonical RNA binding domains and target
sequences (Lukong et al., 2008; Cooper et al., 2009; Darnell,
2010). However, major progress is currently being made in
our understanding of RBP biology, similar to the extensive
achievements concerning the role of microRNAs (miRs) in the
posttranscriptional regulation of target mRNAs. Considerable
accomplishments in this field were obtained from studies devoted
to the systematic discovery of structural elements governing
stability of mammalian mRNAs, the generation of an atlas of
mammalian RBPs and the identification of target RNAs via
high-throughput sequencing of cross-linked RNPs after immuno-
precipitation (Hafner et al., 2010; Zhang and Darnell, 2011;
Castello et al., 2012; Goodarzi et al., 2012).
MicroRNA-MEDIATED REGULATION OF THE DNA
DAMAGE RESPONSE
In addition and complementary to regulation of mRNA sta-
bility and translation by RBPs, posttranscriptional control is
potently exerted by miRs. These recently discovered, yet ubiqui-
tous molecules, 18–24 nucleotides in length, regulate the stability
and/or translation of their target mRNAs by forming imperfect
Watson-Crick base pairs within the 3′ UTR. By virtue of this inter-
action, the microRNA recruits a protein complex referred to as
miRISC (miRNA-induced silencing complex) that exerts transla-
tional repression by a mechanism that is not yet fully understood.
Recently, reported data strongly suggests that destabilization of
target mRNAs, instead of translational repression, is the pre-
dominant mechanism for reduced protein output (Guo et al.,
2010). The minimal protein components of miRISC required
for microRNA-mediated this repression are Argonaute (AGO;
principally AGO2 in mammals and AGO1 in flies) and TNRC6
(trinucleotide repeat containing 6)/GW182 (glycine-tryptophan
protein of 182 kDa) (Guo et al., 2010). One, mechanism of
microRNA function that has been proposed is the sequestra-
tion of their target mRNAs in sub-cellular compartments that
prevent their access to the protein synthesis machinery (Cannell
et al., 2008). Two, such compartments implicated in microRNA
control are SGs and P-bodies (PBs), both related structures act-
ing as sites of triage for repressed mRNA molecules (Cannell
et al., 2008; Buchan and Parker, 2009). The notion that SGs
may play an important role for the DDR arises from a study
by Pothof et al., who showed that UV-induced DNA damage
caused a transient localization of AGO2 to SGs and that cells
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depleted of AGO2 are hypersensitive to UV-irradiation (Pothof
et al., 2009). Furthermore, Zeng et al. demonstrated thatMK2 can
efficiently phosphorylate AGO2 on Ser-387 and this reaction was
induced in HEK293T cells over-expressing AGO2 after treatment
with sodium arsenite (Zeng et al., 2008), a known activator of
the p38MAPK/MK2 pathway. Besides, examining immortalized
human non-small cell lung carcinoma cells (NCI-H1299), the
group showed that mutation of Ser-387 to alanine or pharmaco-
logical inhibition of p38MAPK reduced arsenite-induced AGO2
recruitment into PBs. This points to a potential role for MK2
signaling in the formation of SGs and PBs.
In addition to the global regulation of the DDR by AGO2, spe-
cific miRNAs have been shown to be vitally important for cells
to mount a functional DDR. The first example found were the
miRNAs of the miR-34 family (miR-34a, miR-34b, and miR-34c),
which were simultaneously identified as p53 transcriptional tar-
gets by several groups (Chang et al., 2007; Corney et al., 2007; He
et al., 2007; Tarasov et al., 2007). These miRNAs appear to act as
critical regulators of the DDR by repressing target mRNAs that
regulate the cell cycle and apoptosis. Concretely, data presented
by Raver-Shapira et al. indicates that inhibition of miR-34a, the
most pro-apoptotic member of the miR-34 family, prevented
etoposide-induced cell death to the same extent as p53 depletion,
suggesting that miR-34a is a potent mediator of p53-mediated
apoptosis in this context (Raver-Shapira et al., 2007). The abil-
ity of miR-34a to induce apoptosis may be attributable to its
ability to repress the anti-apoptotic protein BCL-2 via an inter-
action in the 3′ UTR of BCL-1 mRNA (Bommer et al., 2007).
However, Yamakuchi et al. showed that miR-34a represses SIRT1
through its 3′ UTR and that over-expression of SIRT1 rescued
miR-34a-induced apoptosis (Yamakuchi et al., 2008), suggest-
ing that SIRT1 is a functionally important target in that system.
In contrast to miR-34a, miR-34b/c do not seem to regulate cell
death. Rather, these two highly homologous miRNAs inhibit
cell cycle progression in response to DNA damage primarily by
repressing the proto-oncogene C-MYC in both a p53-dependent
and -independent manner (Cannell and Bushell, 2010; Cannell
et al., 2010).
Since the initial finding of miR-34, several other miRNAs reg-
ulating events both proximal and distal to the initial DNA lesion,
have been implicated in the DDR. WIP1 (wild-type p53-induced
phosphatase 1), a key phosphatase targeting critical DDR com-
ponents, such as p53, ATM, and H2AX for dephosphorylation,
is also the target of a miRNA (Takekawa et al., 2000; Lu et al.,
2005; Shreeram et al., 2006). Specifically, the experiments per-
formed by Zhang et al. (2010) revealed that miR-16, a tumor
suppressor miRNA frequently found to be deleted in chronic lym-
phocytic leukemia (CLL), inhibits WIP1 translation (Calin et al.,
2002, 2004; Zhang et al., 2010). According to the authors, WIP1
mRNA levels rapidly increase following DNA damage, while
WIP1 protein fails to accumulate. Further, they went on to show
that miR-16 levels augment rapidly in response to neocarzinos-
tatin, consequently prevent WIP1 protein accumulation and thus
allowing ATM phosphoryaltion to be maintained. At later stages,
likely when DNA repair is complete, miR-16 levels decrease, WIP1
protein accumulates again and ATM is dephosphorylated (Zhang
et al., 2010). These observations are particularly pertinent in
the context of p53 signaling: as well as transcriptionally regu-
lating miR-34, p53 also controls the maturation of certain miR-
NAs including miR-16 in a posttranscriptional manner (Suzuki
et al., 2009). At birth, miRNAs are long primary transcripts
termed pri- miRs and are processed in the nucleus by an enzyme
called Drosha to become a pre-microRNA (60–70 nucleotides in
length). This pre-microRNA is further exported to the cytoplasm
and subjected to the RNAse III enzyme Dicer for final process-
ing (18–24 nucleotides). Interestingly, Suzuki et al. demonstrated
that p53 forms a complex with Drosha by virtue of an inter-
action with the DEAD-box RNA helicase p68 (a.k.a DDX5) to
augment conversion of pri-miR-16 (amongst others) in a DNA
damage-dependent manner (Suzuki et al., 2009). Considering the
observation that WIP1 is also a p53 target gene (Fiscella et al.,
1997), allows us to hypothesize on the following scenario: p53
transcriptionally induces WIP1 and posttranscriptionally induces
miR-16, which limits WIP1 protein production. Upon comple-
tion of DNA repair, miR-16 levels decrease and lead to a rise in
WIP1 protein and attenuation of ATM signaling. It is tempting to
speculate that the association between p53 and p68/DDX5 is reg-
ulated by alternative DNA damage signaling pathways to those,
which control p53-dependent transcription leading to differential
temporal regulation of p53-mediated transcription and miRNA
processing.
In addition to the above, downstream events in the DDR
signaling cascade are also regulated by miRNAs. By generating
cell lines deficient for miR-21, Wang et al. demonstrated that
CDC25A is regulated by this miRNA via its 3′ UTR (Wang et al.,
2009). The analyses of miR-21 deficient RKO colon cancer cells
disclosed increased mitotic entry in response to IR in comparison
to their wild-type counterparts. This phenomenon was largely
blunted by CDC25A depletion, suggesting that miR-21 regu-
lates a DNA damage induced G2/M checkpoint by repressing
CDC25A (Wang et al., 2009). It is therefore possible that DNA
damage imposes a “double-hit” inhibition on CDC25A function
by restraining its translation through miR-21 and promoting its
degradation through Chk1/Chk2/MK2 signaling (Reinhardt and
Yaffe, 2009). However, it remains enigmatic who are the key play-
ers promoting induction of miR-21 in response to DNA damage
and whether this executed at the transcriptional or posttranscrip-
tional level.
Very recently, Gorospe and colleagues have uncovered some
of the mechanisms mediating miR-519-dependent regulation of
the DDR (Abdelmohsen et al., 2012). It was previously known
that miR-519 inhibits cell proliferation. This group now identi-
fied two prominent subsets of miR-519-regulated mRNAs. First,
miR-519 targets mRNAs encoding the DNA maintenance pro-
teins DUT1, EXO1, RPA2, and POLE4 to repress their expression
ultimately resulting in increased DNA damage and upregulation
of CDKN1Ap21. The second group of target mRNAs encoded
proteins involved in calcium homeostasis, such as, ATP2C1 and
ORAI1. Downregulation of these mRNAs raised cytosolic calcium
levels, further increasing p21 levels. Together these alterations
produced an autophagic phenotype in various cell lines.
Although, the majority of studies regarding non-coding RNA
has focused on the function of miRNAs, a plethora of non-
coding transcripts still awaits to be analyzed for their role in
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the DDR [for a detailed review on non-coding RNA in diverse
human diseases see (Esteller, 2011)]. Recently, more than 1000
large intergenic noncoding RNAs (lincRNAs) have been reported
(Khalil et al., 2009). These RNAs are evolutionarily conserved in
mammalian genomes and thus presumably function in diverse
biological processes (Khalil et al., 2009). Interestingly, lincRNA-
p21 (located near the CDKN1A gene encoding the p21 protein) is
transcriptionally regulated by p53 and was also shown to interact
with hnRNP-K, namely by conveying hnRNP-K to the promoter
region of p53 target genes, which in turn become transcription-
ally repressed (Huarte et al., 2010). This lincRNA-p21:hnRNP-K
interaction was observed to be required for proper genomic
localization of hnRNP-K at repressed genes and regulation of
p53-mediated apoptosis (Huarte et al., 2010).
More recently, Wei and colleagues elegantly illustrated that
so-called DSB-induced small RNAs (diRNAs) are transcribed
from sense and antisense strands at, or close to the DSB sites in
Arabidopsis and human cells (Wei et al., 2012). In Arabidopsis, the
biogenesis of diRNAs required ATR, RNA Pol IV, and Dicer-like
proteins. Mutations in these proteins as well as in Pol V prevented
efficient DSB repair (Wei et al., 2012). Subsequently, the authors
provided evidence that diRNAs are recruited by AGO2 to estab-
lish DSB repair in Arabidopsis. Furthermore, depletion of Dicer or
AGO2 in human cells led to a similar decrease in DSB repair effi-
ciency. The authors propose diRNAs to serve as guidingmolecules
directing chromatin modifications or the recruitment of protein
complexes to DSB sites in order to ultimately facilitate DSB repair
(Wei et al., 2012).
GADD45α IS POSTTRANSCRIPTIONALLY REGULATED
IN RESPONSE TO DNA DAMAGE
In addition to p21Cip1/WAF mRNA, which has been demonstrated
to be posttranscriptionally stabilized after DNA damage, Fornace
and colleagues identified Gadd45α mRNA as posttranscription-
ally stabilized in response to genotoxic stress (Jackman et al.,
1994) (Figure 1). Gadd45α is part of a family of genes consist-
ing of Gadd45α, Gadd45β, and Gadd45γ that is widely expressed
in mammalian cells following different stress stimuli. Gadd45α
is induced following hypoxia, IR, oxidants, UV, and growth fac-
tor withdrawal (Zhan, 2005). Gadd45α has been mechanistically
linked to numerous cellular processes, including apoptosis, cell
cycle arrest, nucleotide excision repair and repair-mediated DNA
demethylation, maintenance of genomic stability and signaling
through the p38MAPK, and JNK kinase pathways (Hollander
et al., 1999; Wang et al., 1999; Smith et al., 2000; Amundson
et al., 2002; Hildesheim et al., 2002; Barreto et al., 2007). Gadd45α
expression is rapidly induced after genotoxic stress. This tran-
scriptional activation has initially been thought to be primarily
induced by p53 (Kastan et al., 1992). In fact, p53 was the first tran-
scription factor reported to induce Gadd45α transcription and, at
least in response to IR, Gadd45α transcription strictly depends on
p53 (Kastan et al., 1992). However, it is now clear that additional
transcription factors, including WT1, Oct1, NF-YA, FoxO3a,
Egr-1, and C/EBPα are also capable of inducing Gadd45α tran-
scription, even in the absence of p53 (Constance et al., 1996; Zhan
et al., 1998; Jin et al., 2001; Takahashi et al., 2001; Tran et al., 2002;
Hirose et al., 2003; Thyss et al., 2005). For example, we recently
showed that Gadd45α was induced in p53-deficient murine
embryonic fibroblasts (MEFs) following treatment with doxoru-
bicin (Jiang et al., 2009). In resting cells, Gadd45α transcription
appears to be repressed through c-Myc and a repressive complex
consisting of ZBRK1 and BRCA1 (Marhin et al., 1997; Amundson
et al., 1998; Bush et al., 1998; Zheng et al., 2000; Tan et al., 2004).
Interestingly, c-Myc itself is translationally repressed through
miR-34c via a highly conserved target-site within the 3′ UTR in
response to etoposide-induced DNA damage. While miR-34c can
be induced by p53 following genotoxic stress, Cannell et al. (2010)
showed that miR-34c expression in p53-deficient cells depends
on the p38MAPK/MK2 signaling complex (Cannell et al., 2010).
In addition to this elaborate network of transcriptional control,
Fornace and colleagues reported as early as 1994 that Gadd45α
mRNA is posstranscriptionally stabilized in response to UV or
MMS exposure (Jackman et al., 1994). However, the molecu-
lar details of this posttranscriptional regulation remained largely
obscure. These posttranscriptional regulatory mechanisms might
impact on Gadd45α mRNA molecules at different steps of their
maturation, from their de novo synthesis as pre-mRNA until
the eventual degradation or translation. These steps include pre-
mRNA splicing and maturation (3′ polyadenylation, 5′ capping),
followed by mRNA export to the cytoplasm, sub-cytoplasmic
transport, escape from ribonucleolytic cleavage and translation
(Mitchell and Tollervey, 2000; Orphanides and Reinberg, 2002;
Moore, 2005). Recent studies from Gorospe and co-workers have
identified the RBPs AUF1 and TIAR as critical posttranscrip-
tional regulators of Gadd45α mRNA (Lal et al., 2006). Both
proteins were found to form RNP complexes through a direct
interaction with the 3′ UTR of the Gadd45α mRNA in rest-
ing cells. However, when cells were exposed to UV or MMS
these RNP complexes rapidly dissociated, which correlated with
a substantial increase in Gadd45α mRNA stability an enhanced
association of Gadd45α mRNA with actively translating ribo-
somes and increased Gadd45α protein accumulation (Lal et al.,
2006). When Lal et al. examined the molecular mechanisms of
Gadd45α repression in resting cells, they found AUF1 to render
Gadd45α mRNA unstable while TIAR prevented the association
of Gadd45α mRNA with translating polyribosomes. Thus, the
combined effect of AUF1 and TIAR is a potent repression of
Gadd45α biosynthesis through AUF1-mediated mRNA destabi-
lization and TIAR-dependent translational suppression at resting
state. The genotoxic stress-induced dissociation of AUF1 and
TIAR from the Gadd45αmRNA represents a mechanism of post-
transcriptional derepression resulting in mRNA stabilization and
enhanced translation in response to DNA damage. Both of these
posttranscriptional regulatory steps were found to be essential
for proper induction of Gadd45α protein levels following DNA
damage (Lal et al., 2006).
The report by Lal et al. implicated AUF1 andTIAR as RBPs that
are critical for the posttranscriptional de-repression of Gadd45α
mRNA. However, it remained unclear which molecular mecha-
nisms underlie the DNA damage-induced dissociation of these
RBPs from the Gadd45α mRNA. A plausible explanation might
be DNA damage-dependent phosphorylation events. Indeed,
AUF1 was reported to be a phospho-protein and GSK3β and
PKA were subsequently identified as kinases capable of AUF1
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FIGURE 1 | DDR kinase signaling at the crossroads of cell cycle arrest
and posttranscriptional control of RNA stability. Depicted is a simplified
schematic network integrating key DDR kinases and RNA-binding proteins. In
response to genotoxic stress, ATM activates its effector kinase Chk2 and the
p38MAPK/MK2 kinase complex. Chk2 in turn phosphorylates HuR,
promoting its binding to SIRT1 mRNA. Binding of HuR to additional client
mRNAs, such as p21 mRNA appears to be regulated by MK2, which also
mediates RNA binding of several other RBPs, including PABP1, BRF1, and
TTP. In addition, MK2 phosphorylates hnRNP A0, promoting its binding to and
stabilization of Gadd45αmRNA. In the absence of DNA damage, Gadd45α
mRNA is destabilized and translationally repressed through the RNA-binding
proteins PARN, TIAR, and AUF. These RBPs dissociate from the Gadd45a
mRNA after genotoxic stress. Gadd45α protein is part of a positive feedback
loop that maintains p38/MK2 activity at late times following DNA damage.
Prolonged MK2 activity in turn is required to maintain Cdc25B and C in an
inactive state sequestered in the cytoplasm. Finally, mRNA of numerous
players in DDR signaling is being regulated by miRNAs, which require AGO2
protein to convey their regulation. AGO2 is, in turn, is a phospho-target of
MK2. Green circles indicate DNA damage-activated kinases, red circles
indicate RNA-binding and metabolizing proteins.
phosphorylation in vivo (Zhang et al., 1993; Wilson et al., 2003).
Nonetheless, whether these phosphorylations occur in vivo fol-
lowing genotoxic stress persists to be elusive.
We have recently identified the p38MAPK/MK2 pathway as a
critical regulator of RBPs that mediate posttranscriptional sta-
bilization of Gadd45α mRNA in response to genotoxic stress
(Reinhardt et al., 2010). In analyzing the molecular details of
MK2 function in response to DNA damage, we found that MK2
knockdown prevented the accumulation of Gadd45α mRNA and
protein in response to adriamycin. We identified the known MK2
substrate hnRNP A0 as a novel Gadd45α mRNA-binding pro-
tein (Reinhardt et al., 2010). MK2-mediated phosphorylation of
hnRNPA0 on Ser-84 following DNAdamage was required for the
formation of hnRNP A0:Gadd45α mRNA RNP complexes and
overexpression of a non-phosphorylatable hnRNP A0 on Ser-84
to Ala mutant prevented Gadd45α mRNA and protein accumu-
lation in response to adriamycin (Reinhardt et al., 2010). These
data suggest that MK2-dependent phosphorylation of hnRNP A0
is critical for the formation of hnRNP A0:Gadd45α mRNA RNP
complexes, which in turn appears to be essential for the post-
transcriptional stabilization of Gadd45α mRNA. In addition, we
found that MK2 phosphorylates Poly-(A) ribonuclease (PARN)
on Ser-557 in response to adriamycin (Reinhardt et al., 2010).
Two major pathways of mRNA degradation exist in eukaryotes.
In both cases, shortening of the poly(A) tail is the first, time-
limiting, step. Three distinct protein complexes—Pan2/Pan3, or
PAN complex; PARN; and the Ccr4/Pop2 complex—govern this
deadenylation. After deadenylation, degradation occurs in 3′–5′
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direction through the RNase-containing exosome complex. In
an independent pathway, deadenylation is followed by removal
of the 7-methyl-guanosine cap of mRNAs and then proceeds in
the 5′–3′ direction. The mechanisms of mRNA turnover have
been reviewed recently (Meyer et al., 2004). We found PARN
phosphorylation on Ser-557 to be critical for prolonged Gadd45α
mRNA and protein expression after adriamycin (Reinhardt et al.,
2010). However, the molecular details of this apparent inhibi-
tion of Gadd45α mRNA degradation remain somewhat unclear.
Despite our best efforts, we failed to observe any changes in PARN
activity or RNA binding affinity following MK2-mediated phos-
phorylation on Ser-557 (Schmedding, Reinhardt, Yaffe unpub-
lished). In addition to these MK2-mediated posttranscriptional
mechanisms of Gadd45α mRNA stabilization, we confirmed that
TIAR dissociates from the Gadd45α mRNA in response to geno-
toxic stress (Reinhardt et al., 2010). Furthermore, we could show
that p38MAPK directly phosphorylates TIAR after adriamycin
exposure, both in vitro and in vivo [(Reinhardt et al., 2010)
and Morandell, Reinhardt, Yaffe unpublished]. Pretreatment of
cells with the p38α/β-specific inhibitor SB203580 completely pre-
vented the adriamycin-mediated dissociation of TIAR:Gadd45α
mRNA RNP complexes. Thus, we have identified three novel
mechanisms of posttranscriptional Gadd45α mRNA control. We
identified hnRNP A0 as a critical MK2-dependent posttranscrip-
tional inducer of Gadd45αmRNA. In addition to AUF and TIAR,
which have been described as posttranscriptional repressors of
Gadd45α mRNA, we have identified PARN as a further molecule
that appears to be involved in Gadd45αmRNA repression at rest-
ing state. Lastly, we could show that the DNA damage-induced
dissociation of the TIAR:Gadd45αmRNA RNP complex depends
on p38MAPK-mediated TIAR phosphorylation.
In additional experiments we could confirm data provided by
Bulavin et al. showing that Gadd45α interacts with p38MAPK
(Bulavin et al., 2003). Bulavin et al. further showed that Gadd45α
is critical for H-rasV12-induced activation of p38MAPK.Wemade
a similar observation in response to adriamycin-invoked geno-
toxic stress. RNAi-mediated knockdown of Gadd45α prevented
the prolonged phosphorylation and activation of MK2, likely
through a lack of p38MAPK activity. MK2 remained active in
control cells for at least 30 h. However, MK2 activity dropped
precipitously after ∼24h in Gadd45α-depleted cells. These data
suggest that the initial activation of MK2 after genotoxic stress
does not depend on Gadd45α, but subsequent p38MAPK/MK2-
dependent stabilization of Gadd45α, through phosphorylation
of TIAR, PARN, and hnRNP A0, becomes essential for main-
taining MK2 activity at late times. Further experiments showed
that particularly this late MK2 activity was critical to maintain
checkpoint control after genotoxic stress invoked by doxoru-
bicin through a mechanism involving Cdc25B/C inactivation.
Members of the Cdc25 family of dual-specificity phosphatases are
phosphorylated by the checkpoint effector kinases Chk1 andMK2
in response to DNA damage. We and others previously showed
that the cell cycle arresting checkpoint function of MK2 is medi-
ated through MK2-dependent Cdc25B/C phosphorylation and
subsequent cytoplasmic sequestration (Lopez-Aviles et al., 2005;
Manke et al., 2005; Reinhardt et al., 2007).
We note that MK2 and its activating kinase p38MAPK form
a tight nuclear complex in resting cells (Ben-Levy et al., 1995,
1998; ter Haar et al., 2007). MK2 contains a nuclear localiza-
tion signal (NLS) and a nuclear export signal (NES) located at
the C-terminus. At resting state, the NES is masked by a direct
intramolecular interaction (ter Haar et al., 2007). Following p38-
mediated activating phosphorylation of MK2 on Thr-334, this
interaction is relieved and the NES becomes exposed, resulting in
cytoplasmic translocation of the p38MAPK/MK2 complex (Ben-
Levy et al., 1995, 1998; ter Haar et al., 2007). We could show
that MK2 rapidly leaves the nucleus in response to DNA dam-
age via a Crm1-dependent nuclear export mechanism (Reinhardt
et al., 2010). Thus, we hypothesized that late cytoplasmic MK2
activity might be required to maintain Cdc25B/C sequestered in
the cytoplasm in the context of active cell cycle checkpoints. We
have hence used live cell imaging to follow the subcellular dis-
tribution of Cdc25B and C after genotoxic stress in control cells
or cells that were depleted of either Chk1 or MK2. Cytoplasmic
accumulation of GFP-tagged Cdc25B/C was used as a readout for
active checkpoint signaling. These experiments revealed that adri-
amycin exposure induces a robust cell cycle checkpoint in control
cells that is relieved after ∼30 h and is followed by a cytologically
normal mitotic cell division. Cdc25B/C was maintained in the
cytoplasm until cells entered mitosis. In contrast, Chk1 depletion
resulted in premature nuclear re-entry of Cdc25B/C after ∼15 h,
followed by catastrophic mitotic cell division resulting in apop-
tosis. We observed a similar phenotype in MK2-depleted cells.
However, Cdc25B/C nuclear re-entry did not occur until ∼23 h
following doxorubicin. Intriguingly in this regard is the observa-
tion that this time corresponds perfectly to the time when MK2
activity returned to baseline levels in Gadd45α-depleted cells
that were treated with doxorubicin. These data strongly suggest
that the positive feedback loop involving MK2-dependent sta-
bilization of Gadd45α, and Gadd45α-dependent maintenance of
MK2 activity, are essential for prolonged cell cycle arrest through
cytoplasmic Cdc25B/C sequestration in response to adriamycin.
Together, these data suggest that a feed forward loop consisting
of p38, MK2, and Gadd45α is critical to provide time to recover
from adriamycin-induced genotoxic insults before entering the
next mitotic cell division.
CONCLUDING REMARKS
Posttranscriptional control of gene expression has recently moved
into the focus of scientists working in various areas of life sci-
ences. This is owed to the discovery of miRNA-mediated gene
silencing mechanisms and the uncovering and characterization
of a number of RBPs that are involved in the stabilization and
translatability of mRNAs. The DDR network has classically been
regarded as consisting of a fast-acting kinase signaling branch,
leading to the rapid inactivation of Cdk-cyclin complexes and
a delayed transcriptional response, resulting in the transacti-
vation of genes encoding for Cdk inhibitors, such a p21. As
a consequence of numerous recent discoveries, a clearer pic-
ture is emerging stressing the molecular mechanisms involved
in posttranscriptional control of gene expression and expanding
the complex DDR signaling network with a third layer. These
recent reports strongly suggest that cells employ complex regula-
tory circuits impacting on transcript stability and translatability
in response to genotoxic stress. The major challenges in this
emerging area of research in the field of DNA damage signaling
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are the identification of transcripts that are posttranscriptionally
regulated and the identification and functional characterization
of proteins that mediate this posttranscriptional control. New
technologies, such as, genome-wide RNAi screening and next
generation sequencing of cell lines and primary tumor material
will promote the identification and functional characterization of
non-coding RNAs, RBP, and regulatory RNA sequences involved
in the initiation, maintenance and termination of DDR signaling
in human tissue.
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